Development and validation of a predictive mortality risk score from a European hemodialysis cohort

Kidney International

Volumn 87, Issue 5, 2015, Pages 996-1008

  Floege, Jürgen ^a   Gillespie, Iain A ^b   Kronenberg, Florian ^c   Anker, Stefan D ^d   Gioni, Ioanna ^b   Richards, Sharon ^b   Pisoni, Ronald L ^e   Robinson, Bruce M ^e   Marcelli, Daniele ^f   Froissart, Marc ^g   Eckardt, Kai Uwe ^h  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b AMGEN LTD   (United Kingdom)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^f FRESENIUS MEDICAL CARE   (Germany)

^g AMGEN INC   (United States)

^h UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

epidemiology and outcomes; ESRD; hemodialysis; mortality risk; risk factors

Indexed keywords

C REACTIVE PROTEIN; CREATININE; FERRITIN; HEMOGLOBIN; SERUM ALBUMIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CENTRAL VENOUS CATHETER; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; EUROPEAN; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; MIDDLE AGED; MORTALITY; MORTALITY RISK SCORE; PREVALENCE; PRIORITY JOURNAL; REPRODUCIBILITY; SCORING SYSTEM; VALIDATION PROCESS; VERY ELDERLY; CHRONIC KIDNEY FAILURE; EPIDEMIOLOGY; EUROPE; RISK ASSESSMENT; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; EUROPE; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK ASSESSMENT;

EID: 84929128316     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.419     Document Type: Article

References (46)

1. Eckardt KU, Coresh J, Devuyst O et al. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 2013; 382: 158-169.
2. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
3. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet 2005; 365: 331-340.
4. Kalantar-Zadeh K, Abbott KC, Kronenberg F et al. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol 2006; 26: 118-133.
5. de Jager DJ, Grootendorst DC, Jager KJ et al. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009; 302: 1782-1789.
6. Wright LF. Survival in patients with end-stage renal disease. Am J Kidney Dis 1991; 17: 25-28.
7. Khan IH, Catto GR, Edward N et al. Influence of coexisting disease on survival on renal-replacement therapy. Lancet 1993; 341: 415-418.
8. Foley RN, Parfrey PS, Hefferton D et al. Advance prediction of early death in patients starting maintenance dialysis. Am J Kidney Dis 1994; 23: 836-845.
9. Couchoud C, Labeeuw M, Moranne O et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant 2009; 24: 1553-1561.
10. Miskulin D, Bragg-Gresham J, Gillespie BW et al. Key comorbid conditions that are predictive of survival among hemodialysis patients. Clin J Am Soc Nephrol 2009; 4: 1818-1826.
11. Cohen LM, Ruthazer R, Moss AH et al. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol 2010; 5: 72-79.
12. Liu J, Huang Z, Gilbertson DT et al. An improved comorbidity index for outcome analyses among dialysis patients. Kidney Int 2010; 77: 141-151.
13. van Walraven C, Austin PC, Knoll G. Predicting potential survival benefit of renal transplantation in patients with chronic kidney disease. CMAJ 2010; 182: 666-672.
14. Wagner M, Ansell D, Kent DM et al. Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis 2011; 57: 894-902.
15. Chen JY, Tsai SH, Chuang PH et al. A comorbidity index for mortality prediction in Chinese patients with ESRD receiving hemodialysis. Clin J Am Soc Nephrol 2014; 9: 513-519.
16. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating: New York, 2010.
17. Hosmer DW Jr, Lemeshow S. Applied logistic regression. John Wiley & Sons, 2004.
18. D'Agostino RB Sr, Grundy S et al. Validation of the framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 2001; 286: 180-187.
19. Bradbury BD, Fissell RB, Albert JM et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2007; 2: 89-99.
20. Miskulin DC, Martin AA, Brown R et al. Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant 2004; 19: 413-420.
21. Greenfield S, Apolone G, McNeil BJ et al. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Medical care 1993; 31: 141-154.
22. Takahashi R, Ito Y, Takahashi H et al. Combined values of serum albumin, C-reactive protein and body mass index at dialysis initiation accurately predicts long-term mortality. Am J Nephrol 2012; 36: 136-143.
23. Usvyat LA, Barth C, Bayh I et al. Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to death. Kidney Int 2013; 84: 149-157.
24. Geddes CC, van Dijk PC, McArthur S et al. The ERA-EDTA cohort study-comparison of methods to predict survival on renal replacement therapy. Nephrol Dial Transplant 2006; 21: 945-956.
25. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
26. van Manen JG, Korevaar JC, Dekker FW et al. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis 2002; 40: 82-89.
27. Hemmelgarn BR, Manns BJ, Quan H et al. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-132.
28. Levey AS, Martin AA, Miskulin DC et al. Comorbidity assessment in ESRD: Methods and results in a national dialysis chain. J Am Soc Nephrol 1999; 10: 169A-170A.
29. Thong MS, Kaptein AA, Benyamini Y et al. Association between a selfrated health question and mortality in young and old dialysis patients: a cohort study. Am J Kidney Dis 2008; 52: 111-117.
30. Moss AH, Ganjoo J, Sharma S et al. Utility of the 'surprise' question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol 2008; 3: 1379-1384.
31. Joly D, Anglicheau D, Alberti C et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol 2003; 14: 1012-1021.
32. Kalantar-Zadeh K, Kopple JD, Block G et al. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 2001; 38: 1251-1263.
33. Zoccali C, Tripepi G, Mallamaci F. Predictors of cardiovascular death in ESRD. Semin Nephrol 2005; 25: 358-362.
34. Andreozzi F, Presta I, Mannino GC et al. A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. PloS One 2012; 7: e36224.
35. Postorino M, Marino C, Tripepi G et al. Prognostic value of the New York Heart Association classification in end-stage renal disease. Nephrol Dial Transplant 2007; 22: 1377-1382.
36. Noordzij M, Leffondre K, van Stralen KJ et al. When do we need competing risks methods for survival analysis in nephrology? Nephrol Dial Transplant 2013; 28: 2670-2677.
37. de Francisco AL, Kim J, Anker SD et al. An epidemiological study of hemodialysis patients based on the European Fresenius Medical Care hemodialysis network: results of the ARO study. Nephron Clin Pract 2011; 118: c143-c154.
38. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 2004; 23: 1631-1660.
39. Rubin DB. Multiple imputation for nonresponse in surveys, vol. 519. Wiley Online Library, 1987.
40. Canaud B, Tong L, Tentori F et al. Clinical practices and outcomes in elderly hemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2011; 6: 1651-1662.
41. Pisoni RL, Gillespie BW, Dickinson DM et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis 2004; 44: 7-15.
42. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
43. Chan KE, Maddux FW, Tolkoff-Rubin N et al. Early outcomes among those initiating chronic dialysis in the United States. Clin J Am Soc Nephrol 2011; 6: 2642-2649.
44. Pencina MJ, D'Agostino RB Sr., D'Agostino RB Jr. et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172; discussion 207-112.
45. Kennedy KF, Pencina MJ. A SASs macro to compute added predictive ability of new markers predicting a dichotomous outcome. In, Institute for Advanced Analytics, 2010.
46. Kerr KF, Wang Z, Janes H et al. Net reclassification indices for evaluating risk prediction instruments: a critical review. Epidemiology 2014; 25: 114-121.